Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LiangMin Fu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|April 12, 2026
Targeting the NSUN5-circPPAP2A axis reverses immunosuppression and sensitizes renal cell carcinoma to anti-PD-1 therapyChengpeng Gui, Jinwen Liu, Jinwei Chen, et al.
Cancer Research|February 21, 2024
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell CarcinomaGuannan Shu, Minyu Chen, Wuyuan Liao, et al.
Frontiers in Immunology|October 17, 2022
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinomaLiangmin Fu, Jiahao Bao, Jinhui Li, et al.
Cancer Letters|March 10, 2024
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancerHansen Lin, Liangmin Fu, Xinwei Zhou, et al.
Journal of Translational Medicine|May 24, 2023
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinomaHansen Lin, Liangmin Fu, Pengju Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2023
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1Yihui Pan, Guannan Shu, Liangmin Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 15, 2025
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling SuppressionLiangmin Fu, Wuyuan Liao, Youyan Tan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|April 12, 2026
Targeting the NSUN5-circPPAP2A axis reverses immunosuppression and sensitizes renal cell carcinoma to anti-PD-1 therapyChengpeng Gui, Jinwen Liu, Jinwei Chen, et al.
Cancer Research|February 21, 2024
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell CarcinomaGuannan Shu, Minyu Chen, Wuyuan Liao, et al.
Frontiers in Immunology|October 17, 2022
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinomaLiangmin Fu, Jiahao Bao, Jinhui Li, et al.
Cancer Letters|March 10, 2024
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancerHansen Lin, Liangmin Fu, Xinwei Zhou, et al.
Journal of Translational Medicine|May 24, 2023
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinomaHansen Lin, Liangmin Fu, Pengju Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2023
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1Yihui Pan, Guannan Shu, Liangmin Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 15, 2025
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling SuppressionLiangmin Fu, Wuyuan Liao, Youyan Tan, et al.
Pageof 3